Touyun Biotech Group (1332) Balance Sheet Analysis 2009-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$36.036M	HK$69.644M	HK$11.526M
Net Receivables	HK$96.973M	HK$22.284M	HK$64.247M
Inventory	HK$15.249M	HK$24.585M	HK$17.232M
Prepaid Expenses And Other Current Assets	HK$2.871M	HK$40.88M	HK$0M
Other Current Assets	HK$11.355M	HK$16.66M	HK$28.945M
Total Current Assets	HK$162.484M	HK$174.053M	HK$121.95M
Property, Plant And Equipment	HK$310.631M	HK$280.176M	HK$267.836M
Goodwill And Intangible Assets	HK$0	HK$0	HK$0
Long-Term Investments	HK$134.026M	HK$95.902M	HK$223.237M
Deferred Tax Assets	HK$0	HK$0	HK$0
Other Noncurrent Assets	HK$199K	HK$188K	HK$194K
Total Noncurrent Assets	HK$444.856M	HK$376.266M	HK$491.267M
Other Assets	HK$0	HK$0	HK$0
Total Assets	HK$607.34M	HK$550.319M	HK$613.217M

Metric	2023	2024	LTM
Total Payables	HK$18.473M	HK$12.695M	HK$150.69M
Accrued Expenses	HK$16.912M	HK$0M	HK$0M
Short-Term Debt	HK$164.894M	HK$341.482M	HK$389.559M
Current Portion Of Lease Obligations	HK$14.461M	HK$10.129M	HK$6.395M
Income Taxes Payable	HK$512K	HK$0K	HK$171K
Current Deferred Revenue	HK$18.883M	HK$0M	HK$0M
Other Current Liabilities	HK$147.09M	HK$193.677M	HK$67.978M
Total Current Liabilities	HK$380.713M	HK$557.983M	HK$614.622M
Long-Term Debt	HK$191.45M	HK$26.807M	HK$3.813M
Noncurrent Lease Obligations	HK$14.104M	HK$6.171M	HK$0.949M
Noncurrent Deferred Revenue	HK$0	HK$0	HK$0
Noncurrent Deferred Tax Liabilities	HK$0	HK$0	HK$0
Other Noncurrent Liabilities	HK$0	HK$0	HK$0
Total Noncurrent Liabilities	HK$205.554M	HK$32.978M	HK$4.762M
Other Liabilities	HK$0	HK$0	HK$0
Total Liabilities	HK$586.267M	HK$590.961M	HK$619.384M

Metric	2023	2024	LTM
Treasury Stock	HK$0	HK$0	HK$0
Preferred Stock	HK$0	HK$0	HK$0
Common Stock	HK$112.238M	HK$112.238M	HK$112.238M
Retained Earnings	HK$-2.061B	HK$-2.137B	HK$-2.117B
Additional Paid-In Capital	HK$1.873B	HK$1.873B	HK$1.873B
Accumulated Other Comprehensive Income	HK$39.919M	HK$68.493M	HK$67.571M
Other Stockholders' Equity	HK$34.425M	HK$0M	HK$0M
Total Common Stockholders' Equity	HK$-0.848M	HK$-83.2M	HK$-63.837M
Minority Interest	HK$21.921M	HK$42.558M	HK$57.67M
Total Equity	HK$21.073M	HK$-40.642M	HK$-6.167M
Total Liabilities And Equity	HK$607.34M	HK$550.319M	HK$613.217M

Metric	2023	2024	LTM
Total Investments	HK$135.768M	HK$149.229M	HK$223.237M
Total Debt	HK$384.909M	HK$384.589M	HK$400.716M
Net Debt	HK$350.416M	HK$368.272M	HK$389.19M

Touyun Biotech Group
1332

Balance Sheet

Balance Sheet Composition

Touyun Biotech Group 1332

Balance Sheet

Balance Sheet Composition

Touyun Biotech Group
1332